title: Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice.
abstract: A characteristic clinical feature of dengue virus infection is thrombocytopenia, though its underlying mechanism is not definitively determined. By adoptive transfer of human CD34(+) fetal liver cells into immunodeficient mice, we have constructed humanized mice with significant levels of human platelets, monocytes/macrophages, and hepatocytes. Infection of these mice with both lab-adapted and clinical strains of dengue virus induces characteristic human hematological changes, including transient leukopenia and thrombocytopenia. We show that the specific depletion of human platelets is not mediated by antibodies in the periphery or reduced production of human thrombopoietin in the liver but reduction of human megakaryocytes and megakaryocyte progenitors in the bone marrow of the infected mice. These findings identify inhibition of platelet production in the bone marrow as a key mechanism underlying dengue-induced thrombocytopenia and suggest the utility of the improved humanized mouse model in studying dengue virus infection and pathogenesis in a human cell context.
authors: Singapore-MIT Alliance, Singapore.
authors: Aishwarya
authors: A
authors: Sridharan
authors: Qingfeng
authors: Q
authors: Chen
authors: Kin Fai
authors: KF
authors: Tang
authors: Eng Eong
authors: EE
authors: Ooi
authors: Martin L
authors: ML
authors: Hibberd
authors: Jianzhu
authors: J
authors: Chen
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000473:pathology* / Q000821:virology*; D003715:Dengue / Q000150:complications*; D003716:Dengue Virus / Q000472:pathogenicity*; D006801:Humans; D008533:Megakaryocytes / Q000502:physiology* / Q000821:virology*; D051379:Mice; D016513:Mice, SCID; D013921:Thrombocytopenia / Q000209:etiology*
references: Nat Rev Immunol. 2007 Feb;7(2):118-30
references: 17259968
references: Virology. 1995 Oct 20;213(1):254-7
references: 7483271
references: News Physiol Sci. 2002 Feb;17:6-10
references: 11821529
references: Am J Trop Med Hyg. 1964 Jul;13:642-9
references: 14196064
references: Blood. 2004 Nov 1;104(9):2722-7
references: 15198950
references: J Thromb Haemost. 2007 Nov;5(11):2291-9
references: 17958746
references: Handb Exp Pharmacol. 2012;(210):3-22
references: 22918725
references: Baillieres Clin Haematol. 1995 Mar;8(1):249-70
references: 7663049
references: J Med Virol. 2002 Oct;68(2):241-52
references: 12210415
references: PLoS One. 2011;6(6):e20762
references: 21695193
references: J Virol. 2009 Sep;83(17):8638-45
references: 19535452
references: PLoS One. 2012;7(9):e46292
references: 23050007
references: Nat Med. 2000 Jan;6(1):103-6
references: 10613834
references: Hum Immunol. 2009 Oct;70(10):790-802
references: 19524633
references: Exp Hematol. 2012 Mar;40(3):250-259.e4
references: 22193689
references: Science. 1945 Jun 22;101(2634):640-2
references: 17844088
references: J Med Virol. 2001 Feb;63(2):143-9
references: 11170051
references: J Immunol. 2005 May 15;174(10):6477-89
references: 15879151
references: Blood. 2005 Sep 1;106(5):1565-73
references: 15920010
references: Blood. 2002 Nov 1;100(9):3175-82
references: 12384415
references: Stem Cells. 2013 Jun;31(6):1160-9
references: 23404852
references: Blood. 1999 Jul 1;94(1):97-105
references: 10381502
references: N Engl J Med. 2006 May 11;354(19):2034-45
references: 16687716
references: J Immunol. 2006 Feb 15;176(4):2053-8
references: 16455958
references: Clin Exp Immunol. 2004 Nov;138(2):299-303
references: 15498040
references: Ann Acad Med Singap. 2006 Nov;35(11):783-9
references: 17160194
references: Nat Med. 2004 Jan;10(1):64-71
references: 14702636
references: J Immunol. 2012 Dec 1;189(11):5223-9
references: 23089398
references: PLoS One. 2009 Oct 05;4(10):e7251
references: 19802382